SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following news of a significant deal with OpenAI, with community members speculating about the long-term implications for the company and its competition with Nvidia. The stock's recent surge has sparked discussions around potential future price targets, market capitalization, and whether the current momentum is sustainable. Many are closely watching for potential pullbacks or further upside, drawing parallels to Nvidia's previous AI-driven run.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors discuss its potential as a leader in AI-powered automation, particularly within the agentic economy. Bullish sentiment is fueled by recent partnerships with major players like Nvidia, OpenAI, and Google, sparking speculation about a possible breakout and short squeeze. The community highlights UiPath's strong fundamentals and undervaluation compared to other AI stocks, viewing it as a long-term growth opportunity.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market rallies, fueled by optimism around potential rate cuts and continued AI hype, though some community members express concern about a possible bubble. Discussions revolve around the sustainability of the current pump, potential overvaluation, and the influence of government policies. The Invesco QQQ Trust is hitting new all-time highs, prompting debates about market manipulation and whether a significant pullback is on the horizon.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is seeing high trading volume and price volatility, sparking debate about profit-taking and potential pullbacks as some investors express concerns about its valuation. Community discussions include speculation about upcoming earnings, potential offerings, and comparisons to other quantum computing stocks. Some traders believe RGTI is overbought and due for a correction, while others remain bullish, citing the long-term potential of quantum computing.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending due to recent price volatility and community discussion around its valuation within the quantum computing sector. While some traders are buying the dip, others express concerns about potential dilution and an ongoing SEC investigation, leading to a debate about the stock's future potential and its relation to other quantum computing stocks like IONQ and QBTS. Overall, the community's focus is on whether QUBT can maintain its momentum amidst broader skepticism about the sector's profitability.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending as the lock-up period expired, leading to a significant drop that some community members believe was overdone, presenting a "buy the dip" opportunity. Discussions revolve around a potential short squeeze, comparisons to similar plays like $HOOD, and the possibility of a reversal to previous levels. Some traders are also looking at options activity and technical indicators to determine potential price movements.

TOSHI

TOSHI is trending as community members highlight the coin's bullish chart and potential for new all-time highs. The community is actively discussing strategies to push past resistance levels and anticipating potential exchange listings. Some users are drawing comparisons to other meme coins and highlighting TOSHI's unique position within the Base ecosystem.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the tokenization of Satoshi Nakamoto, viewing it as a tribute to the pseudonymous creator of Bitcoin and a representation of crypto culture. Community members emphasize the limited supply and the narrative's enduring relevance, suggesting it's a play on the 'Bitcoin of memes' with long-term potential. The broader context highlights the significance of honoring the legacy of Satoshi Nakamoto within the crypto space.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending amidst a debate over its valuation and long-term potential in the quantum computing sector. Bulls cite potential government contracts, big tech partnerships and the company's quantum supremacy as reasons for optimism, while bears point to high valuations and a new 2x short ETF ($QBTZ) as signs of a possible correction. Community members are actively discussing whether this surge is sustainable or a bubble about to burst.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

UPC is trending as traders discuss its low market cap relative to its cash reserves, speculating on potential buybacks or strategic moves. The community is watching for news catalysts, especially regarding potential cryptocurrency ventures, which could trigger a price surge. Some are comparing it to recent low-float bio stock runners, anticipating a similar breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Tesla, UnitedHealth, Shopify and Waterstone Financial

Tesla's robotaxi launch, UnitedHealth's cost challenges, and Shopify's AI-driven merchant tools headline Zacks' latest research roundup.

Top Research Reports for Tesla, UnitedHealth & Shopify

Tesla grapples with delivery declines and margin pressure but eyes its robotaxi launch and energy unit as potential growth engines.

UnitedHealth Group (UNH) Laps the Stock Market: Here's Why

The latest trading day saw UnitedHealth Group (UNH) settling at $360.2, representing a +1.83% change from its previous close.

UnitedHealth Group’s (UNH) shareholder Accountability Board has reportedly filed a proposal seeking an independent chairman of the board, separate from the CEO.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-03/unitedhealth-shareholder-wants-chairman-and-ceo-roles-separated">reported</a> on Friday that the nonprofit advocacy group’s proposal, if approved by shareholders, would ask the board to amend the company’s bylaws to codify an independent board chair. Currently, Stephen Hemsley serves as both CEO and chair of the board.“We were very disturbed to see recently that at such a trying time for UnitedHealth, the company chose to go backward and combine the CEO and chair roles,” Accountability Board President Matt Prescott said, as reported by Bloomberg. Prescott also called for a stronger leadership structure at the insurer while declining to disclose the size of the group’s stake in UNH, the report said. However, he noted that the stake meets the minimum requirement to file a shareholder proposal.The report noted that it is unclear whether the Accountability Board’s resolution will proceed to a shareholder vote.Shares of UNH traded 3% higher at the time of writing. On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> remained within the ‘bearish’ territory, while message volume remained at ‘low’ levels.Hemsley has been chairman of the company’s Board of Directors since 2017. Before that, he also served as CEO. He was reappointed as CEO in May when Witty <a href="https://stocktwits.com/news-articles/markets/equity/unitedhealth-suspends-2025-guidance-ceo-andrew-witty-resigns/chi8S4qRbZQ">stepped down</a>, citing personal reasons, but while retaining his chair position. This is contradictory to UnitedHealth’s principle of governance, which also calls for separate roles, Bloomberg noted.The insurer issued <a href="https://stocktwits.com/news-articles/markets/equity/united-health-price-target-lowered-by-bernstein-after-soft-guidance-but-retail-hopes-for-long-term-recovery/chrXElQRdRK">fresh guidance</a> of full-year revenue of $445.5 billion to $448.0 billion and adjusted earnings of at least $16.00 per share in July after suspending its previous outlook in May, citing higher medical costs. The company had previously forecast adjusted profit of $29.50 to $30.00 per share, nearly double its latest forecast. The company also <a href="https://stocktwits.com/news-articles/markets/equity/united-health-s-cfo-shake-up-doesn-t-deter-retail-bulls-traders-call-stock-a-2018-level-opportunity/chr3k1VRdGi">appointed</a> Wayne S. DeVeydt as CFO in July, replacing John F.Rex.UNH stock is down 28% this year and approximately 39% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-gets-price-target-hike-from-jpmorgan-after-q3-deliveries-beat-estimates/chCumk4R3QJ">Tesla Gets A Price Target Hike From JPMorgan After Q3 Deliveries Beat Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report

Stephen Hemsley currently serves as both CEO and Chairman of the Board.

Equity

UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $353.72, denoting a +1.56% move from the preceding trading day.

Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The Pennant Group, Inc. (PNTG) on Thursday said that it has acquired certain operations from UnitedHealth Group (UNH) on October 1The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/02/3160196/0/en/Pennant-Completes-Purchase-of-Tennessee-Georgia-and-Alabama-Operations-from-UnitedHealth-Group-and-Amedisys.html">said</a> that it is purchasing divested home health, hospice, and personal care services in Tennessee, Georgia, and Alabama for a combined purchase price of $146.5 million. These operations were divested as a result of UnitedHealth’s and Amedisys Inc.’s antitrust settlement with the United States Justice Department.Pennant CEO Brent Guerisoli said that the acquisition is part of the company’s strategic move to enter the Southeast United States. The CEO also noted that Pennant will continue to pursue opportunities for growth in the home health, hospice, and senior living industries.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/PNTG">PNTG stock</a> stayed within the ‘neutral’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:1334/120;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_02_at_7_05_11_AM_png_de08f83b6d.webp" alt="PNTG's Sentiment Meter and Message Volume as of 7:05 a.m. ET on Oct. 02, 2025 | Source: Stocktwits" width="1334" height="120"><figcaption>PNTG's Sentiment Meter and Message Volume as of 7:05 a.m. ET on Oct. 02, 2025 | Source: Stocktwits</figcaption></figure>UNH’s Optum unit submitted a proposal to acquire home health and hospice services provider Amedisys in June 2023. UNH had acquired Amedisys’s rival LHC Group earlier that year through a $5.4 billion deal. The U.S. Department of Justice and attorneys general from four U.S. states filed a lawsuit in November 2024 to block the acquisition.Subsequently, in August, the Justice Department’s Antitrust Division <a href="https://stocktwits.com/news-articles/markets/equity/doj-requires-broad-divestitures-1.1-million-fine-to-resolve-unitedhealth-amedisys-merger-challenge/chrmfeNRd3W">said</a> that it requires broad divestitures, including 164 home health and hospice locations across 19 states, to resolve the challenge to UnitedHealth’s planned acquisition of Amedisys. UNH agreed to the divestitures, and the deal was subsequently closed.PNTG stock is down by 4% this year and by 22% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/draftkings-shares-rebound-2-in-premarket/chCr7hMR3Ol">DraftKings Shares Rebound 2% In Premarket As Kalshi Challenge Worries Abate</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Pennant Group Acquires UnitedHealth’s Certain Divested Operations For Nearly $147M – More Details Inside

The company said that it is purchasing divested home health, hospice, and personal care services in Tennessee, Georgia, and Alabama. 

UnitedHealth Group shares&nbsp;declined in premarket trading on Wednesday after the health insurer announced plans to cancel its Medicare Advantage offerings in 109 U.S. counties in 2026, affecting approximately 180,000 members.The decision comes as UnitedHealth and its peers, Humana and CVS Health, move to scale back their Medicare Advantage presence amid mounting cost pressures and lower federal reimbursements.“The combination of (Centers for Medicare and Medicaid Services) funding cuts, rising healthcare costs and increased utilization has created headwinds that no organization can ignore,” said Bobby Hunter, head of UnitedHealth’s government programs, during a Tuesday press briefing, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/unitedhealth-exit-medicare-advantage-plans-16-us-counties-2025-10-01/">report</a>.UnitedHealth will continue operating in most U.S. states and remains the largest Medicare Advantage provider nationwide, ahead of Humana and CVS’s Aetna business.&nbsp;However, the company will close more than 100 plans representing about 600,000 members, primarily preferred provider organizations that allow patients to see out-of-network providers.Hunter stated that most of the plan closures will occur in rural areas, noting that the company is working to develop a sustainable model that can deliver care more efficiently in these communities. The exits are expected to shift more patients toward health maintenance organization (HMO) plans, which typically require in-network referrals.The move follows a challenging year for Medicare-focused insurers, which faced higher-than-expected service utilization and lower government payments. UnitedHealth missed earnings for the first time since 2008 earlier this year and suspended its full-year outlook after costs surged in its Medicare Advantage segment.In July, the company warned that regulatory changes would reduce payments for certain conditions, creating a $4 billion profit risk in 2026. It said plan closures affecting roughly 200,000 members could help offset part of that hit.Hunter added that, compared to 2023, government funding for the program is expected to decline by about 20% by 2026.Competitors are also retrenching. Humana said it will reduce its footprint to 85% of U.S. counties next year, down from 89% in 2025, while CVS Health’s Aetna division will drop plans in about 100 counties and operate in 43 states and Washington, D.C.On Stocktwits, retail sentiment for UnitedHealth and CVS Health was ‘bearish’, with ‘low’ and ‘normal’ message volume, respectively, while sentiment for Humana was ‘neutral’ amid ‘high’ activity.One user noted that the pullback was happening across the board, pointing out that Humana and some Blue Cross plans were also scaling back benefits such as SilverSneakers to prioritize profitability and more substantial margins. The user added that insurers could eventually reenter these markets once conditions improve.&nbsp;<stembedurl>https://stocktwits.com/Beaviez/message/630724173</stembedurl>Another user struck an optimistic tone, saying it was time for UnitedHealth to “set sail” toward $1,050.<stembedurl>https://stocktwits.com/uptrend90/message/630734050</stembedurl>So far this year,&nbsp;<a href="https://stocktwits.com/symbol/UNH">UnitedHealth’s stock</a> has fallen 30%,&nbsp;<a href="https://stocktwits.com/symbol/HUM">Humana</a> is down 2%, while&nbsp;<a href="https://stocktwits.com/symbol/CVS">CVS Health</a> has surged 77%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the UnitedHealth Group logo is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

UnitedHealth Stock Slips Premarket Amid Medicare Advantage Pullback; Humana, CVS Also Tighten Coverage

UnitedHealth joined Humana and CVS Health in cutting back Medicare Advantage plans for 2026 as rising costs and lower federal payments squeeze margins.

Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Eli Lilly's stock jumped over 5% on Tuesday after U.S.President Donald Trump unveiled a plan to lower U.S. drug prices, which included a “TrumpRx” direct-to-consumer website and a pricing agreement with Pfizer.&nbsp;Pfizer became the first company to accept the administration’s terms, agreeing to slash drug prices by up to 85% and secure a three-year exemption from pharmaceutical tariffs.BMO Capital Markets analyst Evan Seigerman said the Pfizer deal effectively provided a model for other drugmakers such as Eli Lilly to balance pricing cooperation with policy compliance. He said the structure gave the administration a political win while avoiding the need for harsher price controls or new tariffs, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-30/pfizer-to-cut-medicaid-drug-prices-in-deal-with-trump-wapo">report</a>.Cantor analyst Carter Gould said the sharp rally in pharmaceutical shares reflected investor relief that the policy measures were more symbolic than financially disruptive. He noted that Pfizer’s announcement did not change any earnings guidance, suggesting that the market viewed the move as a sign of easing regulatory uncertainty rather than a fundamental earnings risk.The S&amp;P 500 Pharmaceuticals Index rose nearly 4%, while Lilly recorded its best day in more than a month. Pfizer climbed nearly 7%, marking its strongest single-day gain in almost four years.Raymond James health policy analyst Chris Meekins said the TrumpRx program was unlikely to materially affect consumers’ costs unless insurance reforms followed. He said that if the administration’s pricing actions stopped at this stage, it would amount to a win for the pharmaceutical industry, CNN&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/2025/09/30/politics/pfizer-drug-prices-trump">noted</a>.Meanwhile, Futurum Equities chief market strategist Shay Baloor&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/StockSavvyShay/status/1973057650150764638">wrote on X</a> that Trump’s agreement with Pfizer to launch TrumpRx, which allows consumers to buy discounted medications directly from manufacturers, could hurt insurers and pharmacy benefit managers.&nbsp;Baloor viewed companies such as Eli Lilly, UnitedHealth, Cigna, and Walgreens as potential losers from the shift, while naming Hims &amp; Hers Health among the likely beneficiaries.Eli Lilly stated that it was in active discussions with the administration to expand patient access, signaling its readiness to participate in broader efforts to increase affordability. The statement followed Trump’s call for drugmakers to align U.S. prices with international levels under his “Most Favored Nation” directive.Commerce Secretary Howard Lutnick said negotiations with major drugmakers were ongoing, while Trump described the plan as a step toward ending what he called global price disparities in medicine.Eli Lilly has not disclosed details of its discussions but said it remains focused on expanding access and improving affordability for patients in the U.S..On Stocktwits, retail sentiment was ‘bullish’ for Eli Lilly and ‘extremely bullish’ for Pfizer, with 24-hour message volumes surging 191% and 780%, respectively.<figure class="image"><img style="aspect-ratio:618/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_30_at_10_14_21_PM_png_d8474c8869.webp" alt="Screenshot 2025-09-30 at 10.14.21 PM.png" width="618" height="55"><figcaption>LLY sentiment and message volume as of 10:15 p.m. ET, Sept. 30 | source: Stocktwits</figcaption></figure>One user noted that the new TrumpRx model, which eliminates middlemen, is unlikely to impact margins for companies such as Eli Lilly, Merck, and Pfizer, describing it as a direct-to-consumer shift.&nbsp;<stembedurl>https://stocktwits.com/Jessdog77/message/630503208</stembedurl>Another user described Eli Lilly as a strong performer that continues to show unstoppable momentum.<stembedurl>https://stocktwits.com/Stonkapedia/message/630566985</stembedurl><a href="https://stocktwits.com/symbol/LLY">Eli Lilly’s stock</a> has declined 0.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/nike-retail-investors-turn-more-bullish-as-q1-performance-confirms-turnaround-progress-good-report-in-difficult-market/chCooXAR39N">Nike Retail Investors Turn More Bullish As Q1 Performance Confirms Turnaround Progress: 'Good Report In Difficult Market'</a>

The entrance to the Eli Lilly factory in Kinsale, Co Cork, where weight loss drug Mounjaro is made. Picture date: Sunday May 18, 2025.

Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma

Analysts said the plan signals a political win that could reshape how major drugmakers engage with U.S. policymakers.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$369.92
Prev Close	$363.66
Open	$366.93
Dividend Yield	1.62%
50-Day Moving Average	$310.47
Beta	0.27
Avg. Volume	13.09M
PE Ratio	15.75

52-Week High	$630.73
52-Week Low	$234.60
Market Capitalization	$329.36B
EPS (Annual)	$15.51
Price to Book	3.47
Revenue Per Employee	$1M
Enterprise Value/EBITDA	N/A

UNH
Unitedhealth Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UNH News

UNH Unitedhealth Group Inc